Data / Form D filings / Adolore Biotherapeutics, Inc.
Adolore Biotherapeutics, Inc.: Form D filings
Adolore Biotherapeutics, Inc., a biotechnology company in Delray Beach, FL, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on September 29, 2025, reports $25,000 sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13685 WHISTLER MOUNTAIN ROAD, Delray Beach, FL, 33446
- Phone
- (973) 524-0935
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1904161
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | New notice | $1,000,000 | $25,000 | $975,000 | 1 | Sep 10, 2025 | sec.gov |
| Jan 25, 2024 | New notice | Indefinite | $1,055,000 | 22 | Dec 15, 2023 | sec.gov | |
| Jan 13, 2022 | New notice | $2,500,000 | $250,000 | $2,250,000 | 3 | Jan 6, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Henry Barone | Executive Officer, Director, Promoter | |
| Mark Henry Rogers | Director | |
| Roelof Henry Rongen | Executive Officer, Director | |
| Roy Henry Levitt | Executive Officer, Director, Promoter |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Sep 29, 2025 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Adolore Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.